Established in 1976, Enzo focuses on developing innovative products and services for improving human healthcare through basic research, drug development, and patient care. Enzo remains at the forefront of target amplification technologies critical in the detection of infectious agents, cancer markers, and genotyping, which opened the door for many of the well-known molecular diagnostics assays in use today.
Enzo’s AMPIPROBE® platform and quality critical reagents enabled rapid response to the SARS-CoV-2 pandemic. We used our expertise to expand our AMPIPROBE® portfolio with additional critical targets. All our AMPIPROBE® products use our innovative AMPIGENE® technology.
|
Our AMPIGENE® PCR Solutions use the latest polymerase technology and buffer chemistry to enable consistent PCR performance.
Advanced PCR technologyAMPIGENE® PCR products use the latest polymerase technology and buffer chemistry to improve PCR performance.
|
Endpoint PCRAMPIGENE® Taq DNA Polymerase |
qPCR and RT-qPCRAMPIGENE® qPCR Green Mix |
Isothermal DNA AmplificationAMPIGENE® Isothermal Amplification Bst Polymerases and Mixes
|
DNA Purification and Contamination ControlgDNA Removal Kit
|
PCR ReagentsAMPIGENE® RNase Inhibitor |
